From a single donation to lifesaving transfusions, scientific discovery and advanced therapies Every blood donation begins with a simple act of generosity. A donor rolls
Why Non-Viable Particle Counters Are Critical for Contamination Control Cleanroom technology continues to evolve as industries face stricter regulatory requirements, higher product quality expectations, and
Foundation supporters and community leaders heard how BioBridge Global is advancing blood donation, laboratory testing, research, and cell therapy innovation. A golden age for medicine
BBG Advanced Therapies Subsidiary of BioBridge Global is advancing our role as an integrated partner for advanced therapy development by delivering cGMP-compliant umbilical cord tissue
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
In a recent webinar, Future Proofing Cell & Gene Therapy: Strategies to Secure Your Leukapheresis Supply Chain, Heather Munoz, Principal of Global Market Development, and James
South Texas Blood & Tissue COO recognized for exceptional leadership and contributions to donor services and transfusion medicine. Audra Taylor, Chief Operating Officer of South
Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally
Honorees recognized by the San Antonio Business Journal reflect innovation, leadership and impact across BioBridge Global and its subsidiaries. Four members of the team at
April marks National Donate Life Month, a time dedicated to encouraging Americans to register as organ, eye and tissue donors while honoring those who have
Emerging discoveries in blood group science highlight the need for advanced testing, donor diversity, and adaptable strategies across transfusion medicine and biotherapeutics. A new blood
Rohini Thevi Guntnur, Ray Rendon III, Joseph Higdon, Deidre Cacchillo, and Rogelio Zamilpa Therapeutic efficacy, reliability, and availability of cell, gene, and tissue-derived therapies have